World Asset Management’s Sarepta Therapeutics SRPT Stock Holding History

World Asset Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,395	Closed	-$238K	–	895
2020 Q4	$238K	Buy	+1,395	New	+$207K	0.02%	744
2020 Q3	–	Sell	-1,341	Closed	-$215K	–	808
2020 Q2	$215K	Buy	+1,341	New	+$182K	0.02%	683
2020 Q1	–	Sell	-2,038	Closed	-$263K	–	1040
2019 Q4	$263K	Buy	+2,038	New	+$206K	0.01%	858
2019 Q3	–	Sell	-2,312	Closed	-$351K	–	1199
2019 Q2	$351K	Buy	2,312 +132	+6%	+$16K	0.02%	784
2019 Q1	$260K	Sell	2,180 -53	-2%	-$6.81K	0.01%	922
2018 Q4	$244K	Buy	2,233 +9	+0.4%	+$1.13K	0.02%	851
2018 Q3	$359K	Buy	2,224 +49	+2%	+$6.7K	0.02%	851
2018 Q2	$287K	Buy	+2,175	New	+$205K	0.01%	981

Other funds holding SRPT

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

World Asset Management's SRPT Position: Q1 2021 in Review

World Asset Management sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 1,395 shares — an estimated $238K sold.

World Asset Management first reported a position in SRPT in Q2 2018 and held it in 8 quarters. The position peaked at $359K in Q3 2018. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

World Asset Management reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
World Asset Management sold 1,395 Sarepta Therapeutics shares in Q1 2021, an estimated $238K.
World Asset Management first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 8 quarters.
World Asset Management's Sarepta Therapeutics position peaked at $359K in Q3 2018.
366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on World Asset Management's 13F filing for Q1 2021, filed 10 May 2021.